Targeted DNA Damage in Glioblastoma: Efficacy, Toxicology, and Clinical Advancements
Time: 12:00 pm
day: Conference Day Two
Details:
- Exploring innovative mechanism of action through targeted DNA damage to selectively kill cancer cells
- Discussing results from orthotopic glioblastoma xenograft studies showing significant efficacy over standard therapies
- Highlighting progress in clinical readiness with completed toxicology studies and upcoming trials
